Cover Image

Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin

COVID-19 has been associated with a high prevalence of myocardial injury and increased cardiovascular morbidity. Copeptin, a marker of vasopressin release, has been previously established as a risk marker in both infectious and cardiovascular disease.

Saved in:
Bibliographic Details
Main Authors: Kaufmann, Christoph C. (Author) , Ahmed, Amro (Author) , Kassem, Mona (Author) , Freynhofer, Matthias K. (Author) , Jäger, Bernhard (Author) , Aicher, Gabriele (Author) , Equiluz-Bruck, Susanne (Author) , Spiel, Alexander O. (Author) , Vafai-Tabrizi, Florian (Author) , Gschwantler, Michael (Author) , Fasching, Peter (Author) , Wojta, Johann (Author) , Giannitsis, Evangelos (Author) , Huber, Kurt (Author)
Format: Article (Journal)
Language:English
Published: 2022
In: Clinical research in cardiology
Year: 2022, Volume: 111, Issue: 3, Pages: 343-354
ISSN:1861-0692
DOI:10.1007/s00392-021-01970-4
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-021-01970-4
Get full text
Author Notes:Christoph C. Kaufmann, Amro Ahmed, Mona Kassem, Matthias K. Freynhofer, Bernhard Jäger, Gabriele Aicher, Susanne Equiluz-Bruck, Alexander O. Spiel, Florian Vafai-Tabrizi, Michael Gschwantler, Peter Fasching, Johann Wojta, Evangelos Giannitsis, Kurt Huber
Description
Summary:COVID-19 has been associated with a high prevalence of myocardial injury and increased cardiovascular morbidity. Copeptin, a marker of vasopressin release, has been previously established as a risk marker in both infectious and cardiovascular disease.
Item Description:Published online: 15 November 2021
Gesehen am 13.04.2022
Physical Description:Online Resource
ISSN:1861-0692
DOI:10.1007/s00392-021-01970-4

Similar Items